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DISCUSSION/CONCLUSION
The CTA “Spot sign” in intracranial hemorrhage has been shown to 
be a reliable imaging sign for determining hematoma expansion (8). 
This sign is an important predictor for pending neurologic decline 
secondary to hemorrhagic expansion and is an indicator for patients 
who may have improved outcomes with aggressive and immediate 
interventions to avoid significant morbidity and mortality (4). One 
such intervention is for craniotomy with hematoma removal which 
can lead to an improved prognosis in “Spot sign” positive patients 
(9). 
It is important to recognize patients with intracranial hemorrhage 
and have CTA performed as soon as possible as it has been shown 
that the longer it takes for the patient to get the CTA, the more the 
positive predictive value of the “Spot sign” decreases (10). In fact, 
CTA followed by 90 second delayed post-contrast CT, also known as a 
“delayed CTA”, is a further predictor of the amount of hematoma 
expansion based on the amount of contrast extravasation, showing 
that the “Spot sign” can measure active bleeding in these patients 
which can help better select patients who may see a benefit from 
additional therapies (6, 7). There is also importance to the timing of 
the CTA, as when the “Spot sign” was seen arterial and therefore 
earlier in the imaging, there was greater expansion of the 
hemorrhage while the later or venous images improved the 
detection of “Spot signs” (11). 
We present the importance of recognizing the “Spot sign” to help 
alert clinicians to the utility of this important diagnostic tool. This is a 
clear sign of impending hematoma expansion and prompt 
recognition is required to guide prognosis and management to 
decrease the morbidity and mortality otherwise expected from a 
rapidly expanding bleed. In our presented case, the quick actions of 
the team in recognizing the “Spot sign” and beginning 3% hypertonic 
saline early led to only mild interval increase in the size of the right 
basal ganglia hemorrhage with some intraventricular extension as 
opposed to the catastrophic possibilities that the “Spot sign” 
signifies.
CASE PRESENTATION
This is a 68-year-old right-handed Caucasian male with no known 
prior medical history other than alcohol abuse who presented 
secondary to a sudden onset of left sided weakness while sitting on 
a barstool. Patient fell to the ground, did not lose consciousness, and 
came in for potential large vessel occlusion. On the initial stat CT 
head without contrast, the patient was noted to have a large right 
supra-tentorial 6.4 x 3.1 cm hemorrhage (Image A). On arrival, the 
patient was noted to be hypertensive with systolic blood pressure as 
high as 195. A CTA head and neck with and without contrast was 
ordered which demonstrated that he did not have evidence of 
vascular malformation but did have evidence of large blush of 
contrast within the hematoma consistent with active hemorrhage 
(Image B). At this time the patient was started on hypertonic 
solutions in the form of 3% hypertonic saline in an urgent fashion. 
Repeat CT head demonstrated a mild interval increase in the size of 
the right basal ganglia hemorrhage with intraventricular extension 
(Image C). With serial CT head imaging without contrast, the 
hemorrhage remained stable, and the hypertonic saline was 
eventually discontinued. His hospital course was complicated by 
delirium tremens in the setting of daily alcoholism, for which he was 
also treated for and subsequently required intubation and eventual 
peg and trach placement. Further neurologic workup including EEGs 
were unremarkable for epileptiform discharges. He continued to 
remain stable from a neurological standpoint. Patient was able to be 
discharged from the hospital to a long-term acute care facility with 
clear instructions for repeat CT head imaging to be done as an 
outpatient. 
REFERENCES
1. Wada R, Aviv RI, Fox AJ, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007 
Apr;38(4):1257-62. doi: 10.1161/01.STR.0000259633.59404.f3. PMID: 17322083
2. Demchuk AM, Dowlatashahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral 
haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012 Apr;11(4):307-14. doi: 
10.1016/S1474-4422(12)70038-8. PMID: 22405630
3. CT angiographic spot sign (intracerebral hemorrhage). Website. 
https://radiopaedia.org/articles/ct-angiographic-spot-sign-intracerebral-haemorrhage?lang=us. Published 2021. Accessed March 20, 2021.
4. Soun JE, Montes D, Yu F, et al. Spot Sign in Secondary Intraventricular Hemorrhage Predicts Early Neurological Decline. Clin Neuroradiol. 2019 
Nov 27. doi: 10.1007/s00062-019-00857-2. Epub ahead of print. PMID: 31776595.
5. Spontaneous intracerebral hemorrhage: Treatment and prognosis.Web site. 
https://www.uptodate.com/contents/spontaneous-intracerebral-hemorrhage-treatment-and-prognosis?search=spot%20sign%20on%20CTA&
source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2. Published 2021. Accessed March 20, 2021.
6. Ciura VA, Brouwers HB, Pizzolato R, et al. Spot sign on 90-second delayed computed tomography angiography improves sensitivity for 
hematoma expansion and mortality: prospective study. Stroke. 2014 Nov;45(11):3293-7. doi: 10.1161/STROKEAHA.114.005570. PMID: 
25300974; PMCID: PMC4213346
7. Brouwers HB, Battery TW, Musial HH, et al. Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma 
Expansion and Mortality in Primary Intracerebral Hemorrhage. Stroke. 2015 Sep;46(9):2498-503. doi: 10.1161/STROKEAHA.115.009659.  PMID: 
26243220; PMCID: PMC4550492
8. Du FZ, Jiang R, Gu M, et al. The accuracy of spot sign in predicting hematoma expansion after intracerebral hemorrhage: a systematic review 
and meta-analysis. PLoS One. 2014 Dec 26;9(12):e115777. doi: 10.1371/journal.pone.0115777. PMID: 25541717; PMCID: PMC4277365
INTRODUCTION
In this poster, we show the utility of the CT Angiogram (CTA) “Spot 
sign” as a predictor of intracranial hematoma expansion and 
subsequent neurologic decline, and demonstrate the measures we 
utilized to decrease the morbidity and mortality of the patient in this 
case report. We discuss the hospital course of a 69-year-old male 
who presented with hypertensive emergency and focal neurologic 
deficits and was found to have a large basal ganglia hypertensive 
bleed with “Spot sign” present on CTA head and neck with and 
without contrast. Patient was treated very aggressively and was 
given hypertonic solutions due to the team’s quick recognition of the 
“Spot sign” signaling potential for future hematoma expansion. 
Though as predicted by the “Spot sign”, his bleed did expand, the 
patient survived with our aggressive measures at the onset of bleed. 
BACKGROUND
The “Spot sign” is a radiographic sign that can be found on a CTA 
study and represents a spot of active extraluminal extravasation and 
accumulation of contrast dye within an intracerebral hemorrhage (1, 
2). Theoretically, the sign has been seen in shape as linear, branching 
or spherical (3). When this sign is identified on imaging, it indicates 
an increased likelihood of significant increase in size of hematoma 
expansion, as this sign is an independent predictor of growth and 
poor outcomes (4). Meta-analysis studies have shown that, "for each 
10% increase in hematoma volume, patients were 5% more likely to 
die and 16% more likely to increase one point on the modified rankin 
scale" (5). However, if identified correctly the “Spot sign” can be 
utilized to identify patients who are most likely to benefit from 
medical and surgical therapy for rapid expansion of intracranial 
hematoma (6, 7). The “Spot sign” serves as a predictor for possible 
hematoma expansion and warrants close neurologic monitoring.
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Image A. Initial CT head 
without contrast 
demonstrating right basal 
ganglia hemorrhage
Image B. The initial CTA 
head and neck with contrast 
demonstrating large blush of 
contrast within the 
hematoma
Image C. Repeat CT head 
without contrast 
demonstrating worsening of 
right basal ganglia 
hematoma with 
interventricular extension
